ABIVAX WKN: A14UQC ISIN: FR0012333284 Kürzel: ABVX Forum: Aktien Thema: Hauptdiskussion

Abivax’s late-breaking abstract on its ABX464 phase 2b clinical data in UC has been accepted for this year’s UEG Week and will be presented by Prof. Séverine Vermeire, M.D., Ph.D, the principal investigator of the study. Participants will have the opportunity to ask questions after the presentation. New data on Abivax’s phase 2b maintenance results, including the first 101 patients who completed 48 weeks of daily treatment with ABX464, will be made public for the first time during the oral presentation.

The UEG Week 2021 takes place virtually from October 3-5, 2021, and is one of the world’s leading congresses focused on gastrointestinal diseases, such as Inflammatory Bowel Diseases (IBD).

Ich glaube nicht, dass die Präsentation davor veröffentlicht wird

Abivax will also be hosting a Live Industry Symposium on ABX464’s potential to address medical needs in UC, presentations will be given by key opinion leaders Prof. Bruce Sands, M.D., M.S. and Prof. William Sandborn, M.D. October 4, 2021, at 1:00-2:00 pm CEST

Principal investigator Prof. Séverine Vermeire, M.D., Ph.D, to present Abivax’s late-breaking abstract on ABX464 phase 2b study results in ulcerative colitis (UC) October 4, 2021, at 10:42-10:54 am CEST

Hab nix gefunden leider 🤷‍♀️

Kann man die Präsentation irgendwo jetzt schon einsehen?

September 28, 2021 12:00 PM EDT Abivax ist mit Late-Breaking-Abstract-Präsentation und Live-Industry-Symposium auf der UEG Week Virtual 2021 vertreten

Ehh schon wieder falsche Richtung…

👌👌👌

Vorläufiges Kursziel im neuen Aktionär: 42€

Wieso ging es heute runter?

Abivax’ late breaking abstract on the phase 2b data in UC was selected for oral presenta-tion during UEG Week Virtual 2021 (Monday, October 4). The data will be presented by the study’s principal investigator, Prof. Séverine Vermeire, M.D., Ph.D. Also, on the same day at UEG Week Virtual 2021, Abivax will host a Live Industry Symposium with presentations by key opinion leaders Prof. Bruce Sands, M.D., M.S. and Prof. William Sandborn, M.D.

🥳🥳🥳🥰

https://www.abivax.com/press-releases/

Und hier the News